Allergan CEO expects drug industry to face pricing heat from Trump

(Reuters) - U.S. President-elect Donald Trump could be more critical of drugmakers and their price increases than the industry expects, Allergan Inc Chief Executive Brent Saunders said on Thursday.

Allergan CEO expects drug industry to face pricing heat from Trump
Read More


Bagikan Berita Ini